Diabetic complications are a leading cause of blindness, renal failure, and nerve damage. Additionally, diabetes-accelerated atherosclerosis leads to increased risk of myocardial infarction, stroke, and limb amputation. At the present time, 4main molecular mechanisms have been implicated in hyperglyceamia-mediated vascular damage. In particular, advancedglycation endproducts (AGE), which are formed by complex, heterogeneous, sugar-derived protein modifications, have beenimplicated as a major pathogenic process for diabetic complications. Recently, AGE inhibitors such as aminoguanidin, ALT-946, and pyridoxamine have been reported. Such an integrating paradigm provides a new conceptual framework for futureresearch on diabetes complications and on discovering drugs to prevent the progression of AGE-induced maladies.
목차
Abstract Introduction Mechanisms of Diabetic Complications A. Polyol pathway B. PKC activation C. Increased hexosamine pathway D. Advanced AGEs AGEs and Diabetic Complications Formation of Various AGEs in vivo and RelatedToxicity AGE Formation During Diabetic Conditions ROS and Diabetes Pharmacological Inhibition of AGEs Conclusion Acknowledgments References
키워드
advanced glycation endproductdiabetes mellitusdiabetic complicationinhibitorreactive oxygen species (ROS)
저자
Hyun-Sun Lee [ Institute of Life Science and Natural Resource, Korea University, Seoul 136-701, Korea ]
Chung-Oui Hong [ Division of Food Bioscience and Technology, College of Life Science and Biotechnology, Korea University, Seoul 136-701, Korea ]
Kwang-Won Lee [ Division of Food Bioscience and Technology, College of Life Science and Biotechnology, Korea University, Seoul 136-701, Korea ]
Corresponding author